Company Description

NuSirt Sciences has developed a platform that evaluates the combined effects of natural compounds and established pharmaceuticals on chronic diseases associated with overnutrition and aging. This system has allowed us to identify potential therapies for a range of cardiometabolic conditions, including metabolic-associated fatty liver disease (MAFLD), metabolic function-associated steatohepatitis (MASH), obesity, type 2 diabetes, and hypertension.